Journal Article
. 2019 Jul; 7(1):194.
doi: 10.1186/s40425-019-0675-0.

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma

Pok Fai Wong 1 Wei Wei 2 Swati Gupta 1 James W Smithy 1 Daniel Zelterman 2 Harriet M Kluger 3 David L Rimm 4 
Affiliations
  • PMID: 31337426
  •     35 References
  •     22 citations

Abstract

Background: The cancer-associated fibroblast (CAF) population is implicated in immune dysregulation. Here, we test the hypothesis that CAF profiles in pretreatment tumor specimens are associated with response to immune checkpoint blockade of programmed cell death 1 (PD-1).

Methods: Pretreatment whole tissue sections from 117 melanoma patients treated with anti-PD-1 therapy were assessed by multiplex immunofluorescence to detect CAFs defined by Thy1, smooth muscle actin (SMA), and fibroblast activation protein (FAP). Two independent image analysis technologies were used: inForm software (PerkinElmer) to quantify cell counts, and AQUA™ to measure protein by quantitative immunofluorescence (QIF). CAF parameters by both methodologies were assessed for association with previously measured immune markers (CD3, CD4, CD8, CD20, CD68, PD-L1), best overall response, progression-free survival (PFS), and overall survival (OS).

Results: CAF parameters, by cell counts or QIF, did not correlate with immune markers nor with best overall response. However, both Thy1 and FAP cell counts had significant positive associations with PFS (all P < 0.05) and OS (all P < 0.003). SMA cell counts showed negative associations with outcome in anti-PD-1 treated patients. Similar associations were not observed in a control cohort of historical melanoma patients predating immunotherapy. Instead, FAP was a negative prognostic biomarker (P = 0.01) in the absence of immunotherapy. Multivariable analyses revealed significant PFS and OS associations with the CAF parameters were independent of baseline variables.

Conclusions: Pretreatment CAF profiles are associated with melanoma immunotherapy outcome. Multiplex CAF analysis has potential as an objective companion diagnostic in immuno-oncology.

Keywords: Biomarkers; Cancer-associated fibroblasts; Fibroblast activation protein; Immunotherapy; Melanoma; PD-1.

Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials.
J Manola, M Atkins, J Ibrahim, J Kirkwood.
J Clin Oncol, 2000 Nov 15; 18(22). PMID: 11078491
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity.
B Hinz, G Celetta, +2 authors, C Chaponnier.
Mol Biol Cell, 2001 Sep 13; 12(9). PMID: 11553712    Free PMC article.
Highly Cited.
Automated subcellular localization and quantification of protein expression in tissue microarrays.
Robert L Camp, Gina G Chung, David L Rimm.
Nat Med, 2002 Oct 22; 8(11). PMID: 12389040
Highly Cited.
A single-institution validation of the AJCC staging system for stage IV melanoma.
Heather B Neuman, Ami Patel, +5 authors, Daniel G Coit.
Ann Surg Oncol, 2008 May 10; 15(7). PMID: 18465172
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, +13 authors, J Verweij.
Eur J Cancer, 2008 Dec 23; 45(2). PMID: 19097774
Highly Cited.
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, +27 authors, Mario Sznol.
N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658127    Free PMC article.
Highly Cited.
A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays.
Wei Huang, Kenneth Hennrick, Sally Drew.
Hum Pathol, 2012 Sep 05; 44(1). PMID: 22944297
Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.
Arjen Joosse, Sandra Collette, +6 authors, Esther de Vries.
J Clin Oncol, 2013 May 22; 31(18). PMID: 23690423
Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.
P Garin-Chesa, L J Old, W J Rettig.
Proc Natl Acad Sci U S A, 1990 Sep 01; 87(18). PMID: 2402505    Free PMC article.
Highly Cited.
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Christine Feig, James O Jones, +12 authors, Douglas T Fearon.
Proc Natl Acad Sci U S A, 2013 Nov 28; 110(50). PMID: 24277834    Free PMC article.
Highly Cited.
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.
Berna C Özdemir, Tsvetelina Pentcheva-Hoang, +18 authors, Raghu Kalluri.
Cancer Cell, 2014 May 27; 25(6). PMID: 24856586    Free PMC article.
Highly Cited.
Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.
Jason R Brown, Hallie Wimberly, +3 authors, Veerle Bossuyt.
Clin Cancer Res, 2014 Sep 27; 20(23). PMID: 25255793    Free PMC article.
Highly Cited.
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, +23 authors, Antoni Ribas.
Nature, 2014 Nov 28; 515(7528). PMID: 25428505    Free PMC article.
Highly Cited.
Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.
Daniel E Carvajal-Hausdorf, Kurt A Schalper, Veronique M Neumeister, David L Rimm.
Lab Invest, 2014 Dec 17; 95(4). PMID: 25502176    Free PMC article.
Review.
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Jeffrey S Weber, Sandra P D'Angelo, +25 authors, James Larkin.
Lancet Oncol, 2015 Mar 22; 16(4). PMID: 25795410
Highly Cited.
Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Caroline Robert, Jacob Schachter, +20 authors, KEYNOTE-006 investigators.
N Engl J Med, 2015 Apr 22; 372(26). PMID: 25891173
Highly Cited.
Genomic Classification of Cutaneous Melanoma.
Cancer Genome Atlas Network.
Cell, 2015 Jun 20; 161(7). PMID: 26091043    Free PMC article.
Highly Cited.
Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction.
Vincent F Fiore, Patrick W Strane, +3 authors, Thomas H Barker.
J Cell Biol, 2015 Oct 16; 211(1). PMID: 26459603    Free PMC article.
Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma.
Pok Fai Wong, Margaret G Gall, +3 authors, Mark D Gorrell.
Peptides, 2015 Dec 02; 75. PMID: 26621486
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Willy Hugo, Jesse M Zaretsky, +15 authors, Roger S Lo.
Cell, 2016 Mar 22; 165(1). PMID: 26997480    Free PMC article.
Highly Cited.
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
Antoni Ribas, Omid Hamid, +25 authors, Caroline Robert.
JAMA, 2016 Apr 20; 315(15). PMID: 27092830
Highly Cited.
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.
Itay Tirosh, Benjamin Izar, +34 authors, Levi A Garraway.
Science, 2016 Apr 29; 352(6282). PMID: 27124452    Free PMC article.
Highly Cited.
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Pei-Ling Chen, Whijae Roh, +41 authors, Jennifer A Wargo.
Cancer Discov, 2016 Jun 16; 6(8). PMID: 27301722    Free PMC article.
Highly Cited.
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports.
Noha Abdel-Wahab, Mohsin Shah, Maria E Suarez-Almazor.
PLoS One, 2016 Jul 30; 11(7). PMID: 27472273    Free PMC article.
Highly Cited. Systematic Review.
Proof of the quantitative potential of immunofluorescence by mass spectrometry.
Maria I Toki, Fabiola Cecchi, +2 authors, David L Rimm.
Lab Invest, 2017 Jan 17; 97(3). PMID: 28092364    Free PMC article.
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.
Yong Qin, Mariana Petaccia de Macedo, +24 authors, Sapna P Patel.
Oncoimmunology, 2017 Jul 07; 6(6). PMID: 28680759    Free PMC article.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, +30 authors, James Larkin.
N Engl J Med, 2017 Sep 12; 377(14). PMID: 28889792    Free PMC article.
Highly Cited.
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.
Vinit Kumar, Laxminarasimha Donthireddy, +27 authors, Dmitry I Gabrilovich.
Cancer Cell, 2017 Nov 15; 32(5). PMID: 29136508    Free PMC article.
Highly Cited.
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells.
Matthew A Lakins, Ehsan Ghorani, +2 authors, Jacqueline D Shields.
Nat Commun, 2018 Mar 07; 9(1). PMID: 29507342    Free PMC article.
Highly Cited.
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Alexander M M Eggermont, Christian U Blank, +26 authors, Caroline Robert.
N Engl J Med, 2018 Apr 17; 378(19). PMID: 29658430
Highly Cited.
Phenotype molding of stromal cells in the lung tumor microenvironment.
Diether Lambrechts, Els Wauters, +15 authors, Bernard Thienpont.
Nat Med, 2018 Jul 11; 24(8). PMID: 29988129
Highly Cited.
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma.
Fei Zhao, Kathy Evans, +6 authors, Brent A Hanks.
Cancer Immunol Res, 2018 Sep 14; 6(12). PMID: 30209062    Free PMC article.
Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma.
Douglas J Hartman, Fahad Ahmad, +2 authors, Liron Pantanowitz.
Oral Oncol, 2018 Nov 10; 86. PMID: 30409313    Free PMC article.
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma.
Pok Fai Wong, Wei Wei, +6 authors, David L Rimm.
Clin Cancer Res, 2019 Jan 09; 25(8). PMID: 30617133    Free PMC article.
Highly Cited.
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
O Eton, S S Legha, +10 authors, R S Benjamin.
J Clin Oncol, 1998 Mar 21; 16(3). PMID: 9508197
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma.
Vera Petrova, Ihor Arkhypov, +4 authors, Viktor Umansky.
Int J Mol Sci, 2020 Apr 03; 21(7). PMID: 32235439    Free PMC article.
Review.
Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors.
Aohan Hou, Kaiyu Hou, +2 authors, Wanling Chen.
Front Immunol, 2020 Jun 09; 11. PMID: 32508809    Free PMC article.
Review.
Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity.
Barbara Érsek, Pálma Silló, +7 authors, Krisztián Németh.
Cell Mol Life Sci, 2020 Apr 25; 78(2). PMID: 32328671    Free PMC article.
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers.
Leonard Kaps, Detlef Schuppan.
Cells, 2020 Sep 10; 9(9). PMID: 32899119    Free PMC article.
Review.
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Jason Yongsheng Chan, Jing Quan Lim, +24 authors, Khee Chee Soo.
J Clin Invest, 2020 Oct 06; 130(11). PMID: 33016928    Free PMC article.
Expression of EMT-Related Genes in Hybrid E/M Colorectal Cancer Cells Determines Fibroblast Activation and Collagen Remodeling.
Irina Druzhkova, Marina Shirmanova, +11 authors, Eugene Sverdlov.
Int J Mol Sci, 2020 Nov 05; 21(21). PMID: 33143259    Free PMC article.
The Influence of Tumor Microenvironment on Immune Escape of Melanoma.
Aleksandra Simiczyjew, Ewelina Dratkiewicz, +3 authors, Dorota Nowak.
Int J Mol Sci, 2020 Nov 12; 21(21). PMID: 33171792    Free PMC article.
Review.
Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies.
Sergi Benavente, Almudena Sánchez-García, +2 authors, Juan Lorente.
Front Oncol, 2020 Nov 17; 10. PMID: 33194719    Free PMC article.
Review.
Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Jiaye Liu, Pengfei Li, +19 authors, Wanlu Cao.
Cell Mol Gastroenterol Hepatol, 2020 Sep 16; 11(2). PMID: 32932015    Free PMC article.
Cancer-associated fibroblasts: overview, progress, challenges, and directions.
Qinrong Ping, Ruping Yan, +6 authors, Ruhong Li.
Cancer Gene Ther, 2021 Mar 14; 28(9). PMID: 33712707
Review.
Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical Applications.
Yannick Van Herck, Asier Antoranz, +4 authors, Francesca Maria Bosisio.
Front Oncol, 2021 Apr 16; 11. PMID: 33854972    Free PMC article.
Review.
PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research.
Yu Zhang, Guang-Ze Mou, +7 authors, Cheng-Hao Jin.
Technol Cancer Res Treat, 2021 Mar 25; 20. PMID: 33759637    Free PMC article.
Review.
Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.
Veronica Romano, Immacolata Belviso, +7 authors, Alessandro Arcucci.
Int J Mol Sci, 2021 Jun 03; 22(10). PMID: 34067929    Free PMC article.
Review.
Understanding the tumor microenvironment for effective immunotherapy.
Habib Sadeghi Rad, James Monkman, +4 authors, Arutha Kulasinghe.
Med Res Rev, 2020 Dec 06; 41(3). PMID: 33277742    Free PMC article.
Review.
Fibroblasts Influence the Efficacy, Resistance, and Future Use of Vaccines and Immunotherapy in Cancer Treatment.
Bailee H Sliker, Paul M Campbell.
Vaccines (Basel), 2021 Jul 03; 9(6). PMID: 34200702    Free PMC article.
Review.
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.
Gurcan Gunaydin.
Front Oncol, 2021 Aug 03; 11. PMID: 34336660    Free PMC article.
Review.
High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer Immunotherapy.
Camelia Quek, Xinyu Bai, +2 authors, James S Wilmott.
Genes (Basel), 2021 Oct 24; 12(10). PMID: 34681023    Free PMC article.
Review.
Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy.
Zhengshuo Li, Xiaoyue Zhang, Can Liu, Jian Ma.
Front Cell Dev Biol, 2021 Nov 02; 9. PMID: 34722510    Free PMC article.
Review.
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.
Robert A Szczepaniak Sloane, Michael G White, +20 authors, Jennifer A Wargo.
Cancers (Basel), 2021 Nov 14; 13(21). PMID: 34771465    Free PMC article.
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer.
Tyler MacNeil, Ioannis A Vathiotis, +5 authors, David L Rimm.
Cancers (Basel), 2021 Nov 14; 13(21). PMID: 34771664    Free PMC article.
Leptin Receptor Overlapping Transcript (LEPROT) Is Associated with the Tumor Microenvironment and a Prognostic Predictor in Pan-Cancer.
Bingsheng Li, Yao He, Pan Li, Xiang Chen.
Front Genet, 2021 Nov 23; 12. PMID: 34804118    Free PMC article.
Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression.
YiHeng Du, Jin Cao, +5 authors, BoXin Xue.
Cancer Cell Int, 2021 Nov 22; 21(1). PMID: 34801033    Free PMC article.